Back to DODGE & COX

REGN
Showing 8 of 18 quarters

Position history for DODGE & COX's holdings in REGENERON PHARMACEUTICALS

DODGE & COX holds 4.5M shares of REGN (REGENERON PHARMACEUTICALS), worth $3.4B as of 2026-Q1. The position was decreased (-3.0% shares). REGN represents 1.9% of DODGE & COX's portfolio.

Current Value

$3.4B

Current Shares

4.5M

Total Value Change

+$1B

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
4.5M
-3.0%
$3.4B1.9%$766.66
0
2025-Q4
Increased
4.6M
+1.0%
$3.5B1.9%$773.94
51
2025-Q3
Increased
4.6M
+18.9%
$2.6B1.4%$560.05
59
2025-Q2
Increased
3.8M
+64.6%
$2B1.1%$519.56
73
2025-Q1
Increased
2.3M
+0.1%
$1.5B0.8%$634.66
45
2024-Q4
Increased
2.3M
+0.4%
$1.7B1.0%$698.71
45
2024-Q3
Decreased
2.3M
-0.2%
$2.4B1.4%$1,036.94
0
2024-Q2
Decreased
2.3M
-1.9%
$2.4B1.5%$1,045.23
0

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used